Prostate-specific antigen doubling time as a surrogate marker for evaluation of oncologic drugs to treat prostate cancer

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)3927-3933
Number of pages7
JournalClinical Cancer Research
Volume10
Issue number11
DOIs
Publication statusPublished - Jun 1 2004

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Kelloff, G. J., Coffey, D. S., Chabner, B. A., Dicker, A. P., Guyton, K. Z., Nisen, P. D., ... D'Amico, A. V. (2004). Prostate-specific antigen doubling time as a surrogate marker for evaluation of oncologic drugs to treat prostate cancer. Clinical Cancer Research, 10(11), 3927-3933. https://doi.org/10.1158/1078-0432.CCR-03-0788